APA

Hata A. N., Yeo A., Faber A. C., Lifshits E., Chen Z., Cheng K. A., Walton Z., Sarosiek K. A., Letai A., Heist R. S., Mino-Kenudson M., Wong K. & Engelman J. A. (20140828). Failure to induce apoptosis via BCL-2 family proteins underlies lack of efficacy of combined MEK and PI3K inhibitors for KRAS-mutant lung cancers. : Cancer research.

Chicago

Hata Aaron N, Yeo Alan, Faber Anthony C, Lifshits Eugene, Chen Zhao, Cheng Katherine A, Walton Zandra, Sarosiek Kristopher A, Letai Anthony, Heist Rebecca S, Mino-Kenudson Mari, Wong Kwok-Kin and Engelman Jeffrey A. 20140828. Failure to induce apoptosis via BCL-2 family proteins underlies lack of efficacy of combined MEK and PI3K inhibitors for KRAS-mutant lung cancers. : Cancer research.

Harvard

Hata A. N., Yeo A., Faber A. C., Lifshits E., Chen Z., Cheng K. A., Walton Z., Sarosiek K. A., Letai A., Heist R. S., Mino-Kenudson M., Wong K. and Engelman J. A. (20140828). Failure to induce apoptosis via BCL-2 family proteins underlies lack of efficacy of combined MEK and PI3K inhibitors for KRAS-mutant lung cancers. : Cancer research.

MLA

Hata Aaron N, Yeo Alan, Faber Anthony C, Lifshits Eugene, Chen Zhao, Cheng Katherine A, Walton Zandra, Sarosiek Kristopher A, Letai Anthony, Heist Rebecca S, Mino-Kenudson Mari, Wong Kwok-Kin and Engelman Jeffrey A. Failure to induce apoptosis via BCL-2 family proteins underlies lack of efficacy of combined MEK and PI3K inhibitors for KRAS-mutant lung cancers. : Cancer research. 20140828.